Research: here's why sleep can play an important role in heart health

Editorial note (initial): This article was originally published in the past and has been updated according to scientific and popular criteria to reflect consolidated evidence and recent reviews. The content is for informational purposes only and does not replace individual medical advice.

IN BRIEF

• Sleep is linked, along with other lifestyle factors, to a lower incidence of cardiovascular events in observational literature.
• Population studies show a "U-shaped" profile (increased risk for very short and very long sleep) and suggest that sleeping around 7 hours is associated with lower risks.
• Plausible mechanisms include effects on metabolism, blood pressure, inflammation, and autonomic function; some genetic analyses (Mendelian randomization) provide support for potentially causal relationships for short sleep and certain cardiovascular diseases.
• Most evidence is observational: useful for informing prevention policies and research, but does not in itself prove that modifying sleep automatically reduces risk in every individual.

Abstract: what does science say?

Sleep is a daily behavior with physiological and social relevance. Numerous large cohort observational studies indicate that both very short and very long sleep durations are associated with increased risks of cardiovascular diseases and mortality. Studies that have added sleep duration measurement to traditional lifestyle scores report an increase in cardio-protective benefits when sleep is adequate. Plausible biological mechanisms include metabolic alterations, increased blood pressure, autonomic dysfunction, and inflammatory markers. Recent genetic analyses provide signals of partial causality between short sleep and some cardiovascular diseases, but uncertainties remain related to sleep measurement, residual confounding, and variability across populations. In summary: epidemiological evidence supports sleep as an important element for cardiovascular health, but interpretation requires methodological caution and further interventionally oriented studies.

What is meant by "sufficient sleep"?

In scientific debate, the term "sufficient sleep" is often defined in terms of hours per night, with 7 hours as a commonly used threshold in large epidemiological studies. This threshold is a population average and does not reflect individual needs: the optimal quantity varies with age, health status, and sleep quality. Furthermore, the subjective perception of being rested may differ from the absolute duration. For this reason, many studies combine self-reported duration measures with quality indices or with objective recordings (actigraphy/polysomnography) when available. Recommendations based on observational data must take into account this individual variability and the limitations of measurement.

Main section: evidence and interpretation

Epidemiological evidence: cohorts and meta-analyses

Several cohort studies on large and different populations have shown associations between sleep duration and cardiovascular risk. An important cohort study in the Netherlands reported that adding sleep duration (≥7 hours) to classic lifestyle factors (diet, physical activity, smoking, alcohol consumption) was associated with an additional reduced composite risk of cardiovascular events, compared to the four traditional factors alone [1]. Meta-analyses and systematic reviews, on the other hand, have highlighted a complex picture: many reviews show a "U" or "J" shaped trend, with increased risk for very short sleep and for prolonged sleep compared to an intermediate reference [2].

Relationship with diabetes and metabolic factors

The association between sleep and type 2 diabetes risk is supported by meta-analyses of prospective studies showing an increased risk for short sleep durations (and in some works for very long durations) compared to a 7–8 hour reference [4]. Mechanistically, chronic sleep reduction affects insulin sensitivity, appetite, and energy balance; these changes may at least partially mediate the observed increase in metabolic risk. However, the direction of the relationship can be influenced by pre-existing conditions that alter sleep (e.g., nocturnal breathing disorders or systemic conditions) and related behavioral factors.

Plausible biological mechanisms

There are several plausible biological pathways linking sleep to cardiovascular risk factors: alterations in the autonomic system (increased sympathetic component), elevated blood pressure, metabolic dysregulation (insulin resistance, increased adipose tissue), and activation of inflammatory processes measurable with proteins such as CRP and IL-6. Systematic reviews and meta-analyses on inflammatory markers show that sleep disturbances and abnormal duration are associated with higher levels of pro-inflammatory biomarkers, although the results are not completely consistent for all measures and populations [5].

Evidence of causality: what genetic studies suggest

In recent years, genetic analyses (Mendelian randomization) have been conducted using genetic variants associated with sleep duration as "instruments" to test causal relationships. Some studies published in high-impact cardiovascular journals suggest that genetic predisposition to shorter sleep is associated with higher risks for several cardiovascular diseases, including heart attack and hypertension, offering support for a possible causal effect of chronic sleep deprivation on some cardiovascular outcomes [7]. These results strengthen the plausibility of the relationship but do not fully resolve the complexities related to measurement, genetic pleiotropy, and generalizability across populations.

What it means in practice

For the general public, current evidence can be summarized as follows: sleep is a relevant element for cardiovascular health and metabolic health; consistently sleeping too few or too many hours compared to an intermediate reference is associated with higher risks in the studied populations. This does not imply that every person who sleeps little will develop heart disease, nor that intervening on sleep will automatically resolve all risks. However, evaluating sleep along with other risk factors (diet, physical activity, smoking, alcohol, body weight, blood pressure, glycemia) is consistent with an integrated prevention approach.

General non-prescriptive indications

Reading the data suggests some practical, non-prescriptive actions: monitor sleep duration and quality in the context of one's health; report persistent very short or very long sleep, frequent insomnia, excessive daytime sleepiness, or suspected sleep apnea to a healthcare professional; consider sleep as a variable to improve along with other lifestyle factors when discussing cardiovascular prevention. Personalized interventions and clinical evaluation remain necessary in the presence of symptoms or risk conditions.

Key takeaways

• Observational evidence indicates that sleep duration is associated with cardiovascular risk in a non-linear way; a commonly used reference is about 7 hours per night.
• Sleep is part of the lifestyle factors that influence CVD risk, but most evidence is observational and subject to confounding.
• There are plausible biological mechanisms (metabolism, blood pressure, inflammation, autonomic system) that link sleep to cardiometabolic risk factors.
• Mendelian randomization genetic analyses suggest that short sleep may play a causal role in some cardiovascular diseases, but further confirmation and interventional studies are needed.

Limitations of the evidence

It is crucial to distinguish between association and causality. Most evidence comes from observational studies with self-reported sleep measures, which can be imprecise and influenced by pre-existing health conditions. Possible limitations include residual confounding (e.g., socioeconomic conditions, uncollected comorbidities), measurement bias of sleep duration and quality, heterogeneity in the definition of "short" or "long" duration, and differences between populations. Even meta-analyses show variability between studies and sometimes significant heterogeneity. Genetic analyses provide useful information on potentially causal relationships but can be influenced by pleiotropy and limitations in the ancestral representativeness of genetic studies. For these reasons, practical interpretation requires caution and clinical contextualization.

Editorial conclusion

The scientific literature supports the idea that sleep is a relevant element for cardiovascular and metabolic health at the population level. Evidence suggests that maintaining a sleep duration that is neither extremely short nor excessively long is associated with lower risks, and that sleep can amplify the benefits of other healthy behaviors. However, the majority of evidence remains observational: well-designed intervention studies are needed to establish if and how improving sleep leads to a lasting reduction in cardiovascular events. In the meantime, evaluating sleep as part of an integrated approach to prevention remains a reasonable and informed choice for public and clinical health.

Editorial note (end of article)

This article has been updated to reflect available scientific literature and integrate key references for transparency. The material is informative and does not replace personalized medical evaluation. For clinical questions, consult your doctor or a qualified healthcare professional.

SCIENTIFIC RESEARCH

1. Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: The MORGEN study. Eur J Prev Cardiol. 2014;21:1367-1375. https://doi.org/10.1177/2047487313493057
2. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32:1484-1492. https://doi.org/10.1093/eurheartj/ehr007
3. Self-Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose-Response Meta-Analysis. J Am Heart Assoc. 2018;7:e008552. https://doi.org/10.1161/JAHA.118.008552
4. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33:414-420. https://doi.org/10.2337/dc09-1124
5. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort and experimental studies. Biol Psychiatry. 2016;80:40-52. https://doi.org/10.1016/j.biopsych.2015.05.014
6. Insomnia and risk of cardiovascular disease: a meta-analysis (Eur J Prev Cardiol). 2014;21:57-64. https://doi.org/10.1177/2047487312460020
7. Causal associations of short and long sleep durations with 12 cardiovascular diseases: linear and nonlinear Mendelian randomization analyses in UK Biobank. Eur Heart J. 2021;42:3349-3357. https://doi.org/10.1093/eurheartj/ehab170
8. Sleep duration and risk of stroke and coronary heart disease: a 9‑year community-based prospective study of 0.5 million Chinese adults. BMC Neurol. 2023;23:327. https://doi.org/10.1186/s12883-023-03367-4

DOI Checklist (internal control): for each source above, the public DOI and its relevance to the topic discussed have been verified.